Evidence map›Paper›PMID 42415586›Full record

ArticleThe Canadian journal of urology2026

Evolution toward early stent removal and reduced antibiotic prophylaxis post-cystectomy.

Jessica L Wenzel, Wesley H Chou, Eric J Robinson, Solange Bassale, Paul Jones, Sudhir Isharwal, Christopher L Amling, Kamran P Sajadi, Jen-Jane Liu

Abstract read
PubMed Publisher
In one paragraph

Article in The Canadian journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jessica L WenzelDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Wesley H ChouDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Eric J RobinsonUrology Los Angeles Medical Center, Kaiser Permanente, Los Angeles, CA 90027, USA.
Solange BassaleKnight Cancer Institute, Oregon Health & Science University, Portland, OR 97239, USA.
Paul JonesSt. Luke's Clinic Urology, Caldwell, ID 83605, USA.
Sudhir IsharwalDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Christopher L AmlingDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Kamran P SajadiDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.
Jen-Jane LiuDepartment of Urology, Oregon Health & Science University, Portland, OR 97239, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe ideal duration of ureteral stents in cystectomy is unknown, with trends toward earlier removal or foregoing them altogether. To reduce the duration of indwelling stents and antibiotics, we modified the cystectomy pathway at our institution from ~2 weeks of stenting with 30 days of antibiotic prophylaxis to stent removal before discharge with prophylaxis ending one day after stent removal. We evaluated rates of urinary tract infection (UTI) and urine leak in cystectomy patients after these changes.

methodsWe performed a retrospective review of patients undergoing cystectomy with ileal conduit diversion at our institution from 2016-2022. Patients were stratified into early vs. late stent removal (postoperative day [POD] ≤5 or >5). Primary outcomes were the 30-day rate of UTI (positive urine culture with symptoms requiring antibiotics) and urine leak (postoperative drain creatinine measurement ≥2× serum creatinine).

resultsOf 228 patients, 19% had early stent removal. Mean stent removal was POD 4 vs. 18 days in the early vs. late group. The early stent removal group had shorter antibiotic exposure (8.2 vs. 21.9 days, p < 0.001). No differences between the early vs. late stent removal groups were seen for postoperative UTI (9.3 vs. 10.8%, p = 0.77), urine leak (2.3% vs. 2.2%, p = 0.96), or readmission rates (9.3 vs. 11.4%, p = 0.69). No difference in the rate of hydronephrosis on postoperative imaging was noted between the two groups.

conclusionsIterative decreases in ureteral stent duration as part of a quality improvement initiative enabled reduced postoperative antibiotic exposure without increasing adverse outcomes, including UTI, urine leak, or postoperative hydronephrosis.

Indexed as

Antibiotic ProphylaxisCystectomyDevice RemovalPostoperative ComplicationsStentsUrinary Tract InfectionsAgedFemaleHumansMaleMiddle AgedRetrospective StudiesTime FactorsUreterUrinary Diversionclostridioides difficileradical cystectomystents, antibioticsurinary tract infections

Identifiers

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.